| Financial Year |
September 30 2022 |
| Monetary Funds |
3,985,711,472.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,541,205,986.80 |
| Advances to Suppliers |
69,165,269.01 |
| Other Receivables |
27,307,551.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,366,486,207.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
639,982,984.50 |
| Total Current Assets |
11,629,859,471.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
44,747,402.02 |
| Investment Properties |
4,633,416.50 |
| Fixed Assetes |
102,215,153.34 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
13,691,869.00 |
| R&D expenses |
-- |
| Goodwill |
4,819,658.89 |
| Long-Term Deferred and Prepaid Expenses |
48,085,235.58 |
| Deferred Income Tax Assets |
81,175,468.79 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
534,071,454.89 |
| Total Assets |
12,163,930,926.59 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
4,115,701,717.13 |
| Notes Payable |
-- |
| Accounts Payable |
118,512,188.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,919,192.36 |
| Taxes Payable |
55,053,647.35 |
| Interest Payable |
13,235,350.15 |
| Dividend Payable |
-- |
| Other payables |
265,427,765.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,500,949.09 |
| Other Current Liabilities |
56,243,434.41 |
| Sub-Total of Current Liabilities |
5,090,123,010.85 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
275,663.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
222,665,113.42 |
| Total Liabilities |
5,312,788,124.27 |
| Paid-In Capital(Or Share Stock) |
1,680,000,000.00 |
| Capital Surplus |
2,396,571,794.81 |
| Surplus Reserve |
197,964,750.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,492,314,712.39 |
| Minority Stockholder's Interest |
84,289,243.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,766,853,558.75 |
| Owner's Equity（Stockholder's Equity） |
6,851,142,802.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,163,930,926.59 |
